Steven D Passik

Summary

Affiliation: University of Kentucky
Country: USA

Publications

  1. ncbi request reprint Opioid therapy in patients with a history of substance abuse
    Steven D Passik
    Symptom Management and Palliative Care Program, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0093, USA
    CNS Drugs 18:13-25. 2004
  2. ncbi request reprint A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, 800 Rose Street, CC449, Lexington, KY 40536 0093, USA
    Clin Ther 26:552-61. 2004
  3. ncbi request reprint A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study
    Steven D Passik
    Hoosier Oncology Group, Walther Cancer Institute, Indianapolis, Indiana, USA
    Cancer Invest 22:383-8. 2004
  4. ncbi request reprint Pain clinicians' rankings of aberrant drug-taking behaviors
    Steven D Passik
    Chandler Medical College, and Marky Cancer Center, University of Kentucky, Lexington, KY 40536 0093, USA
    J Pain Palliat Care Pharmacother 16:39-49. 2002
  5. ncbi request reprint Managing pain in patients with aberrant drug-taking behaviors
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
    J Support Oncol 3:83-6. 2005
  6. ncbi request reprint Assessing aberrant drug-taking behaviors in the patient with chronic pain
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, 800 Rose Street, CC125, Lexington, KY 40536 0093, USA
    Curr Pain Headache Rep 8:289-94. 2004
  7. ncbi request reprint A feasibility study of dignity psychotherapy delivered via telemedicine
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
    Palliat Support Care 2:149-55. 2004
  8. ncbi request reprint Initial validation of a scale to measure purposelessness, understimulation, and boredom in cancer patients: toward a redefinition of depression in advanced disease
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
    Palliat Support Care 1:41-50. 2003
  9. ncbi request reprint Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study
    Kenneth L Kirsh
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
    Clin J Pain 18:S52-60. 2002
  10. ncbi request reprint A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain
    Steven D Passik
    Oncology Symptom Control and Research, Community Cancer Care, Indianapolis, IN, USA
    J Pain Symptom Manage 23:526-32. 2002

Detail Information

Publications55

  1. ncbi request reprint Opioid therapy in patients with a history of substance abuse
    Steven D Passik
    Symptom Management and Palliative Care Program, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0093, USA
    CNS Drugs 18:13-25. 2004
    ....
  2. ncbi request reprint A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, 800 Rose Street, CC449, Lexington, KY 40536 0093, USA
    Clin Ther 26:552-61. 2004
    ..During long-term treatment, this assessment should focus on a broad range of outcomes, each of which should be documented in the medical record...
  3. ncbi request reprint A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study
    Steven D Passik
    Hoosier Oncology Group, Walther Cancer Institute, Indianapolis, Indiana, USA
    Cancer Invest 22:383-8. 2004
    ..Therefore, olanzapine may be an effective agent for the prevention of chemotherapy-induced DE. A phase II trial is underway...
  4. ncbi request reprint Pain clinicians' rankings of aberrant drug-taking behaviors
    Steven D Passik
    Chandler Medical College, and Marky Cancer Center, University of Kentucky, Lexington, KY 40536 0093, USA
    J Pain Palliat Care Pharmacother 16:39-49. 2002
    ..Further inquiry could be used to guide clinicians' responses to aberrant behaviors when encountered in patients on controlled substances for pain...
  5. ncbi request reprint Managing pain in patients with aberrant drug-taking behaviors
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
    J Support Oncol 3:83-6. 2005
  6. ncbi request reprint Assessing aberrant drug-taking behaviors in the patient with chronic pain
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, 800 Rose Street, CC125, Lexington, KY 40536 0093, USA
    Curr Pain Headache Rep 8:289-94. 2004
    ..The assessment of aberrant behaviors in patients with chronic pain is one key aspect of mastering these principles...
  7. ncbi request reprint A feasibility study of dignity psychotherapy delivered via telemedicine
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
    Palliat Support Care 2:149-55. 2004
    ..We delivered the Dignity Psychotherapy intervention in a feasibility study of a series of eight cancer patients via videophone technology to deliver the therapy into their homes...
  8. ncbi request reprint Initial validation of a scale to measure purposelessness, understimulation, and boredom in cancer patients: toward a redefinition of depression in advanced disease
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
    Palliat Support Care 1:41-50. 2003
    ..We were interested in developing a Purposelessness, Understimulation, and Boredom (PUB) Scale to identify this problem and to begin to differentiate it from depression...
  9. ncbi request reprint Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study
    Kenneth L Kirsh
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
    Clin J Pain 18:S52-60. 2002
    ....
  10. ncbi request reprint A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain
    Steven D Passik
    Oncology Symptom Control and Research, Community Cancer Care, Indianapolis, IN, USA
    J Pain Symptom Manage 23:526-32. 2002
    ..0, p < 0.005). No extrapyramidal symptoms were noted and mental status exams were not changed over the course of the eight days. These results suggest an antiemetic effect for olanzapine and indicate the need for a controlled trial...
  11. ncbi request reprint An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients
    Dale E Theobald
    Oncology Symptom Control and Research, Community Cancer Care, Indianapolis, Indiana, USA
    Palliat Support Care 1:71-7. 2003
    ..Clinical experience suggests that antidepressants of virtually all types are well tolerated and potentially efficacious. There is, however, a lack of an evidence base for the use of antidepressants in cancer patients...
  12. ncbi request reprint Difficulties in screening for adjustment disorder, Part II: An attempt to develop a novel self-report screening instrument in cancer patients undergoing bone marrow transplantation
    Kenneth L Kirsh
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
    Palliat Support Care 2:33-41. 2004
    ..Bone marrow transplantation (BMT) has a high level of morbidity that can cause significant stress for patients faced with the procedure...
  13. ncbi request reprint A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, KY 40536 0093, USA
    J Pain Symptom Manage 25:485-8. 2003
    ..These data suggest that olanzapine was well tolerated and may reduce the incidence of delayed emesis in patients receiving moderate to highly emetogenic chemotherapy. A series of prospective trials are underway...
  14. ncbi request reprint A pilot study of oncology staff perceptions of palliative care and psycho-oncology services in rural and community settings in Indiana
    Steven D Passik
    Community Cancer Care, Inc, Oncology Symptom Control Research, Indianapolis, IN 46202, USA
    J Rural Health 18:31-4. 2002
    ..Conclusions are tempered by important study limitations but the results suggest the need for programs that improve delivery of palliative care in rural Indiana...
  15. ncbi request reprint Initial development of a survey tool to detect issues of chemical coping in chronic pain patients
    Kenneth L Kirsh
    Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky 40536 0082, USA
    Palliat Support Care 5:219-26. 2007
    ..We have used the term chemical coping to describe this vast middle ground and seek to begin a line of research starting with the development of a clinically useful tool to identify this subset of patients...
  16. ncbi request reprint A chart review, pilot study of two single-item screens to detect cancer patients at risk for cachexia
    Kenneth L Kirsh
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington 40536 0093, USA
    Palliat Support Care 1:331-5. 2003
    ....
  17. ncbi request reprint Use of a depression screening tool and a fluoxetine-based algorithm to improve the recognition and treatment of depression in cancer patients. A demonstration project
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington 40536, USA
    J Pain Symptom Manage 24:318-27. 2002
    ..Such an approach may benefit patients, and, if kept simple, can be incorporated into day-to-day care of people with cancer...
  18. ncbi request reprint Difficulties in screening for adjustment disorder, Part I: Use of existing screening instruments in cancer patients undergoing bone marrow transplantation
    Kenneth L Kirsh
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
    Palliat Support Care 2:23-31. 2004
    ..This is especially true with regard to identifying adjustment disorder (AD), despite the fact that AD is the most prevalent psychiatric diagnosis in cancer patients...
  19. ncbi request reprint The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain
    Steven D Passik
    Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA
    Pain Med 4:186-9. 2003
  20. ncbi request reprint An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms
    Dale E Theobald
    Oncology Symptom Control and Research, Community Cancer Care, Indianapolis, Indiana 46202, USA
    J Pain Symptom Manage 23:442-7. 2002
    ..This open-label pilot study suggests that mirtazapine may be effective for improving multiple symptoms, depression and quality of life in patients with advanced cancer. A controlled trial of this drug would be valuable...
  21. ncbi request reprint Patient-related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaire
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA
    J Pain Symptom Manage 24:481-93. 2002
    ..Multiple barriers contribute to why cancer patients do not comment about fatigue but may be overcome if physicians screen and assess for this symptom...
  22. ncbi request reprint An unsuccessful attempt to develop a single-item screen for insomnia in cancer patients
    Steven D Passik
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, KY, USA
    J Pain Symptom Manage 25:284-7. 2003
    ..The use of this single item, or perhaps any single item, as a means of screening for sleep disturbances in cancer patients may be problematic. A better understanding of insomnia and its measurement are worthwhile areas of study...
  23. ncbi request reprint Palliative care of the terminally ill drug addict
    Kenneth L Kirsh
    Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky 40536 0082, USA
    Cancer Invest 24:425-31. 2006
    ..Implications for the field are discussed...
  24. ncbi request reprint My mind is as clear as it used to be: A pilot study illustrating the difficulties of employing a single-item subjective screen to detect cognitive impairment in outpatients with cancer
    Gail Kibiger
    University of Indianapolis, Indiana, USA
    J Pain Symptom Manage 26:705-15. 2003
    ..We conclude that while the perception of cognitive impairment is common in cancer patients, there may be problems in interpreting the nature of these complaints, particularly in separating them from depressive preoccupation...
  25. ncbi request reprint Hospice staff members' views on conducting end-of-life research
    Kenneth L Kirsh
    Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, 800 Rose Street, CC129, Lexington, KY 40536 0093, USA
    Palliat Support Care 2:273-82. 2004
    ..This survey study was designed to examine hospice staff attitudes, beliefs, and values about research with their patients and family members...
  26. ncbi request reprint Brief report: pain and readiness to quit smoking cigarettes
    Ellen J Hahn
    University of Kentucky College of Nursing, Lexington, KY 40536 0232, USA
    Nicotine Tob Res 8:473-80. 2006
    ..Placing formal tobacco dependence treatment programs within pain clinics and addressing pain in smoking cessation programs is recommended...
  27. doi request reprint Pseudoaddiction revisited: a commentary on clinical and historical considerations
    Steven D Passik
    Pain Treatment Center of the Bluegrass, 2416 Regency Road, Lexington, KY 40503, USA
    Pain Manag 1:239-48. 2011
    ..g., excusing the use of marijuana for pain or symptom control while on opioids for non-malignant pain). ..
  28. doi request reprint Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain
    John F Peppin
    The Pain Treatment Center of the Bluegrass, Lexington, KY, USA
    Pain Med 13:886-96. 2012
    ....
  29. ncbi request reprint Reality and responsibility: a commentary on the treatment of pain and suffering in a drug-using society
    Steven D Passik
    Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Opioid Manag 2:123-7. 2006
    ....
  30. ncbi request reprint An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire by Holmes et al
    Steven D Passik
    Pain Pract 6:69-71. 2006
  31. ncbi request reprint A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study
    Rudolph M Navari
    Notre Dame Cancer Institute, University of Notre Dame, 224 Raclin Carmichael Hall, Notre Dame, IN 46556, USA
    Support Care Cancer 15:1285-91. 2007
    ....
  32. ncbi request reprint Will the number of milligrams of an opioid dose ever re-achieve the truly meaningless status it deserves?
    Steven D Passik
    Memorial Sloan Kettering Cancer Center and Weil Medical College of Cornell University, New York, New York 10021, USA
    J Pain Palliat Care Pharmacother 21:39-41. 2007
    ..This commentary posits that clinicians must return to the principles of balancing efficacy with toxicity as the dose-limiting factor once again, contextualized by outcomes in the areas of function and compliant drug-taking...
  33. ncbi request reprint King of pain: what Elvis's death tells us about media coverage of celebrities and the pain/addiction interface
    Steven D Passik
    J Opioid Manag 3:69-70. 2007
  34. ncbi request reprint Commentary: reflections on the Cicero et al. paper (PDS 06 0174.R2)
    Steven D Passik
    Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA
    Pharmacoepidemiol Drug Saf 16:841-4. 2007
  35. ncbi request reprint Commentary on Jung and Reidenberg's "Physicians being deceived": aberrant drug-taking behaviors: what pain physicians can know (or should know)
    Steven D Passik
    Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Pain Med 8:442-4; author reply 447-8. 2007
  36. ncbi request reprint Management of chronic noncancer pain in the primary care setting
    Bruce Nicholson
    Pain Specialists of Greater Lehigh Valley, Allentown, PA 18103, USA
    South Med J 100:1028-36. 2007
    ..Ongoing monitoring should focus on the 4 A's (ie, analgesia, activities of daily living, adverse effects, and aberrant drug-related behaviors), and all aspects of patient care must be thoroughly documented...
  37. pmc Challenges in using opioids to treat pain in persons with substance use disorders
    Seddon R Savage
    Dartmouth Medical School, Hanover, New Hampshire 03755, USA
    Addict Sci Clin Pract 4:4-25. 2008
    ..The authors consider that every pain complaint deserves careful investigation and every patient in pain has a right to effective treatment...
  38. ncbi request reprint Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the Pain Assessment and Documentation Tool
    Steven D Passik
    Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Opioid Manag 1:257-66. 2005
    ..e., addiction or diversion) in only approximately 10 percent of cases. Using the PADT physician ratings can be developed in four domains. In this sample, outcomes suggested that opioid therapy provided meaningful analgesia...
  39. ncbi request reprint Weighing in on the off-label use of Actiq for noncancer-related pain: a recipe for success or a recipe for disaster?
    Steven D Passik
    Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10022, USA
    Pain Med 8:130-3. 2007
    ..Specifically, the case is made that using oral transmucosal fentanyl citrate in noncancer patients, for whom there is no current indication, is contributing to the prescription drug abuse problem...
  40. ncbi request reprint Substance abuse issues in cancer pain
    Laurie A Whitcomb
    Community Cancer Care, Inc, Oncology Symptom Control Research, 115 West 19th Street, Indianapolis, IN 46202, USA LAWhitMAI
    Curr Pain Headache Rep 6:183-90. 2002
    ..In this paper, we will explore pertinent conceptual and clinical aspects of addiction that can assist in improving the identification and treatment of patients with substance use disorders...
  41. ncbi request reprint Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology Group Study
    Michael J Fisch
    The University of Texas M D Anderson Cancer Center, Unit 008, Rm P12 2911, 1515 Holcombe Blvd, Houston, TX 77030 4009, USA
    J Clin Oncol 21:2754-9. 2003
    ..To evaluate the association between quality-of-life (QOL) impairment as reported by patients and QOL impairment as judged by nurses or physicians, with and without consideration of spiritual well-being (SWB)...
  42. ncbi request reprint A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group study
    Rudolph M Navari
    Walter Cancer Research Center, University of Notre Dame, 250 Nieuwland Science Hall, Notre Dame, IN 46556, USA
    Support Care Cancer 13:529-34. 2005
    ..Olanzapine is safe and highly effective in controlling acute and delayed chemotherapy-induced nausea and vomiting in patients receiving highly and moderately emetogenic chemotherapy...
  43. ncbi request reprint Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse
    Steven D Passik
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Clin J Pain 22:173-81. 2006
    ....
  44. ncbi request reprint Pain management misstatements: ceiling effects, red and yellow flags
    Steven D Passik
    Memorial Sloan Kettering Cancer Center
    Pain Med 7:76-7. 2006
  45. ncbi request reprint A pilot study to examine the relationship between boredom and spirituality in cancer patients
    Alice Inman
    Department of Behavioral Medicine, Brooke Army Medical Center, San Antonio, Texas, USA
    Palliat Support Care 1:143-51. 2003
    ..The current study was conducted to investigate the relationship between spirituality and boredom, constraint, social contact, and depression...
  46. ncbi request reprint A pilot study of the impact of a grief camp for children
    Laura Nabors
    Department of Psychology, Mail Location 376, University of Cincinnati, Cincinnati, OH 45221 0376, USA
    Palliat Support Care 2:403-8. 2004
    ..Research indicates that children benefit from supportive interventions to help them cope with the loss of a loved one. The aim of this pilot study was to evaluate children's perceptions of the effectiveness of a grief camp...
  47. ncbi request reprint A pilot examination of the impact of cancer patients' fatigue on their spousal caregivers
    Steven D Passik
    Memorial Sloan Kettering Cancer Center, Department of Psychiatry and Behavioral Sciences, 641 Lexington Avenue, New York, NY 10022, USA
    Palliat Support Care 3:273-9. 2005
    ..In this pilot project we examined the quality of life of spouses of cancer patients who had significant fatigue...
  48. ncbi request reprint Fear and loathing in the pain clinic
    Steven D Passik
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Pain Med 7:363-4; discussion 365-6. 2006
  49. ncbi request reprint Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation
    Steven D Passik
    Memorial Sloan Kettering Cancer Center and Cornell University Weil College of Medicine, New York, NY, USA
    J Pain Palliat Care Pharmacother 20:5-13. 2006
    ..v. administration. Implications for pain management are discussed, focusing on the need for clinicians treating chronic pain to more thoroughly assess patients for their risk of abuse and addiction before starting an opioid regimen...
  50. ncbi request reprint Challenges in the development of prescription opioid abuse-deterrent formulations
    Nathaniel P Katz
    Tufts University School of Medicine, Boston, MA, USA
    Clin J Pain 23:648-60. 2007
    ....
  51. ncbi request reprint Is there a model for demonstrating a beneficial financial impact of initiating a palliative care program by an existing hospice program?
    Steven D Passik
    Memorial Sloan Kettering Cancer Center, 1242 Second Avenue, New York, New York 10021, USA
    Palliat Support Care 2:419-23. 2004
    ..We end with a series of questions: Are there financial benefits? Can they be modeled and quantified? Is this a dilemma for hospice programs wanting to improve the quality of care but who are not able on their own to finance it?..
  52. ncbi request reprint Re. Probing the paradox of patients' satisfaction with inadequate pain management
    Steven D Passik
    J Pain Symptom Manage 24:361-3. 2002
  53. ncbi request reprint Empathy and the failure to treat pain
    Steven D Passik
    Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Palliat Support Care 5:167-72. 2007
    ..Ultimately, we hope to push forward an agenda of rational therapy in pain management that utilizes safeguards against abuse and addiction while also preserving treatment modalities for patients in need of services...
  54. ncbi request reprint Same as it ever was? Life after the OxyContin media frenzy
    Steven D Passik
    J Pain Symptom Manage 25:199-201. 2003
  55. pmc Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress
    Kristi D Graves
    Cancer Control Program, Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC 20007, USA
    Lung Cancer 55:215-24. 2007
    ..Identification of the presence and predictors of distress are the first steps toward appropriate referral and treatment of symptoms and problems that contribute to cancer patients' distress...